Specific killing of P53 mutated tumor cell lines by a cross-reactive human HLA-A2-restricted P53-specific CTL line.
about
Immunologic aspect of ovarian cancer and p53 as tumor antigen.Bridging innate and adaptive antitumor immunity targeting glycans.The role of p53 in the immunobiology of cutaneous squamous cell carcinoma.Recombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansion.Therapeutic cancer vaccines in combination with conventional therapy.Effects of X-radiation on lung cancer cells: the interplay between oxidative stress and P53 levels.
P2860
Specific killing of P53 mutated tumor cell lines by a cross-reactive human HLA-A2-restricted P53-specific CTL line.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Specific killing of P53 mutate ...... tricted P53-specific CTL line.
@en
type
label
Specific killing of P53 mutate ...... tricted P53-specific CTL line.
@en
prefLabel
Specific killing of P53 mutate ...... tricted P53-specific CTL line.
@en
P2093
P2860
P356
P1476
Specific killing of P53 mutate ...... tricted P53-specific CTL line.
@en
P2093
H S Poulsen
L O Pedersen
M H Claesson
P A Würtzen
P2860
P304
P356
10.1002/IJC.1417
P577
2001-09-01T00:00:00Z